Filippo Pigazzani
Overview
Explore the profile of Filippo Pigazzani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
418
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manfredini R, Pigazzani F, Colussi G, Cosci F
J Psychosom Res
. 2025 Feb;
191:112072.
PMID: 40011190
No abstract available.
2.
Cappuccio F, Manfredini R, Pigazzani F
J Hypertens
. 2025 Jan;
43(2):201-202.
PMID: 39748735
No abstract available.
3.
Carbone A, Flacco M, Manzoli L, Lamberti N, Pigazzani F, Rega S, et al.
Curr Probl Cardiol
. 2024 Aug;
49(11):102804.
PMID: 39163922
Takotsubo syndrome (TTS) might exhibit particular chronobiological patterns in its onset, characterized by variations according to time of the day, day of the week, and month of the year. The...
4.
Pigazzani F, Dyar K, Morant S, Vetter C, Rogers A, Flynn R, et al.
EClinicalMedicine
. 2024 May;
72:102633.
PMID: 38774676
Background: Timing drug administration to endogenous circadian rhythms may enhance treatment efficacy. In the Chronotype sub-study of the Treatment in Morning versus Evening (TIME) clinical trial we examined whether timing...
5.
Mackenzie I, Hawkey C, Ford I, Greenlaw N, Pigazzani F, Rogers A, et al.
Health Technol Assess
. 2024 Mar;
28(18):1-55.
PMID: 38551218
Background: Allopurinol is a xanthine oxidase inhibitor that lowers serum uric acid and is used to prevent acute gout flares in patients with gout. Observational and small interventional studies have...
6.
Mackenzie I, Rogers A, Poulter N, Williams B, Brown M, Webb D, et al.
Lancet
. 2022 Oct;
400(10361):1417-1425.
PMID: 36240838
Background: Studies have suggested that evening dosing with antihypertensive therapy might have better outcomes than morning dosing. The Treatment in Morning versus Evening (TIME) study aimed to investigate whether evening...
7.
Mackenzie I, Hawkey C, Ford I, Greenlaw N, Pigazzani F, Rogers A, et al.
Lancet
. 2022 Oct;
400(10359):1195-1205.
PMID: 36216006
Background: Allopurinol is a urate-lowering therapy used to treat patients with gout. Previous studies have shown that allopurinol has positive effects on several cardiovascular parameters. The ALL-HEART study aimed to...
8.
Pigazzani F, Gorni D, Dyar K, Pedrelli M, Kennedy G, Costantino G, et al.
Antioxidants (Basel)
. 2022 Aug;
11(8).
PMID: 36009260
Oxidative stress participates in the development and exacerbation of cardiovascular diseases (CVD). The ability to promptly quantify an imbalance in an individual reductive-oxidative (RedOx) state could improve cardiovascular risk assessment...
9.
Mangini F, Muscogiuri E, Del Villano R, Rosato R, Casavecchia G, Pigazzani F, et al.
Arch Clin Cases
. 2022 Jul;
9(2):41-49.
PMID: 35813494
Mitral annular disjunction is related to increased arrhythmogenic risk; in a certain percentage of cases, mitral annular disjunction is associated with tricuspid annular disjunction. While the prognostic implications of mitral...
10.
Rogers A, Rooke E, Morant S, Guthrie G, Doney A, Duncan A, et al.
BMJ Open
. 2022 Jun;
12(6):e060583.
PMID: 35649591
Objectives: To describe the incidence of adverse events (AEs), reactogenicity symptoms, menstrual changes and overall self-rated improvement in health and well-being after COVID-19 vaccination. Design: VAC4COVID is an ongoing prospective,...